Issue Contents
|
|
Marketing Authorisations
|
|
|
|
|
Not sufficiently flexible to meet patients' needs
|
|
|
|
|
|
|
|
|
|
|
|
No advantage over bortezomib
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reviews
|
|
|
|
|
First-choice treatments
|
|
|
|
|
|
|
|
|
|
Testing rarely useful after a venous thromboembolic event
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The complete contents of
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated.
